The State authorities company stated the corporate’s product, Johnson’s Baby Powder, might have an effect on the pores and skin of new child infants
The State authorities company stated the corporate’s product, Johnson’s Baby Powder, might have an effect on the pores and skin of new child infants
Maharashtra’s Food and Drugs Administration (FDA) has cancelled the infant powder manufacturing licence of Johnson & Johnson Pvt Ltd “in the interest of public health at large.” In a launch issued on Friday, the State authorities company stated the corporate’s product, Johnson’s Baby Powder, might have an effect on the pores and skin of new child infants.
Samples of the powder for infants didn’t conform to plain pH worth throughout a laboratory take a look at, the regulator stated.
The launch stated the motion was taken after Kolkata-based Central Drugs Laboratory’s conclusive report that concludes “the sample does not conform to IS 5339:2004 with respect to the test for pH.” According to the discharge, FDA had drawn samples of Johnson’s Baby Powder from Pune and Nashik for high quality test functions.
The authorities analyst had declared the samples as “not of the standard quality” as they don’t adjust to IS 5339:2004 specification for pores and skin powder for infants within the take a look at pH, it stated.
Thereafter, FDA issued a show-cause discover to Johnson and Johnson underneath the Drugs Cosmetics Act 1940 and Rules, moreover issuing directions to the corporate to recall the inventory of the stated product from market, stated the discharge.
The agency “didn’t accept the report” of the federal government analyst and challenged it in court docket for sending it to the Central Drugs Laboratory, it added.
Source: www.thehindu.com